Spero Therapeutics Stock Price on September 23, 2024
| SPRO Stock | USD 1.33 0.01 0.76% |
Below is the normalized historical share price chart for Spero Therapeutics extending back to November 02, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Spero Therapeutics stands at 1.33, as last reported on the 11th of November 2024, with the highest price reaching 1.34 and the lowest price hitting 1.31 during the day.
If you're considering investing in Spero Stock, it is important to understand the factors that can impact its price. As of now, Spero Stock is unstable. Spero Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0391, which indicates the firm had a 0.0391% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Spero Therapeutics, which you can use to evaluate the volatility of the company. Please validate Spero Therapeutics' Semi Deviation of 1.84, coefficient of variation of 2567.55, and Risk Adjusted Performance of 0.0368 to confirm if the risk estimate we provide is consistent with the expected return of 0.11%.
As of the 11th of November 2024, Common Stock Shares Outstanding is likely to grow to about 55.6 M, while Total Stockholder Equity is likely to drop about 84.2 M. . As of the 11th of November 2024, Price Earnings Ratio is likely to grow to 3.57, while Price To Sales Ratio is likely to drop 0.76. Spero Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of November 2017 | 200 Day MA 1.4421 | 50 Day MA 1.2979 | Beta 0.631 |
Spero |
Sharpe Ratio = 0.0391
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | SPRO | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.74 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Spero Therapeutics is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spero Therapeutics by adding it to a well-diversified portfolio.
Price Book 0.8863 | Enterprise Value Ebitda 0.65 | Price Sales 0.6023 | Shares Float 40.5 M | Wall Street Target Price 5 |
Related Headline
CytomX Therapeutics Headline on 23rd of September 2024
Acquisition by Marcia Belvin of 60000 shares of CytomX Thera... by Marcia Belvin
Filed transaction by CytomX Therapeutics Officer: Svp, Chief Scientific Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Spero Therapeutics Valuation on September 23, 2024
It is possible to determine the worth of Spero Therapeutics on a given historical date. On September 23, 2024 Spero was worth 1.35 at the beginning of the trading date compared to the closed value of 1.3. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Spero Therapeutics stock. Still, in general, we apply an absolute valuation method to find Spero Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Spero Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Spero Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.37 | 1.37 | 1.32 | 1.33 | 129,386 | |
09/23/2024 | 1.35 | 1.36 | 1.30 | 1.30 | 80,228 |
| 1.29 | 1.31 | 1.24 | 1.28 | 131,389 |
| Backtest Spero Therapeutics | | | Spero Therapeutics History | | | Spero Therapeutics Valuation | Previous | Next |
Spero Therapeutics Trading Date Momentum on September 23, 2024
| On September 24 2024 Spero Therapeutics was traded for 1.28 at the closing time. The top price for the day was 1.31 and the lowest listed price was 1.24 . The trading volume for the day was 131.4 K. The trading history from September 24, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 1.54% . The trading price change against the current closing price is 2.31% . |
Spero Therapeutics Fundamentals Correlations and Trends
By evaluating Spero Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Spero Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Spero financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Spero Therapeutics Stock history
Spero Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Spero is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Spero Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Spero Therapeutics stock prices may prove useful in developing a viable investing in Spero Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 53 M | 55.6 M | |
| Net Loss | -41.8 M | -43.9 M |
Spero Therapeutics Quarterly Net Working Capital |
|
Spero Therapeutics Stock Technical Analysis
Spero Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Spero Therapeutics Period Price Range
Low | November 11, 2024
| High |
0.00 | 0.00 |
Spero Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Spero Therapeutics November 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Spero Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Spero Therapeutics shares will generate the highest return on investment. By undertsting and applying Spero Therapeutics stock market strength indicators, traders can identify Spero Therapeutics entry and exit signals to maximize returns
Spero Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Spero Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Spero Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Spero to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0368 | |||
| Jensen Alpha | 0.0454 | |||
| Total Risk Alpha | (0.47) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.2991 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spero Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Spero Stock, please use our How to Invest in Spero Therapeutics guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spero Therapeutics. If investors know Spero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spero Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.753 | Earnings Share 0.34 | Revenue Per Share 2.223 | Quarterly Revenue Growth 2.754 | Return On Assets 0.1048 |
The market value of Spero Therapeutics is measured differently than its book value, which is the value of Spero that is recorded on the company's balance sheet. Investors also form their own opinion of Spero Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Spero Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spero Therapeutics' market value can be influenced by many factors that don't directly affect Spero Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spero Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spero Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spero Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.